Ongoing Phase I clinical trial (JPH034) being conducted in the United States
In order to lay the foundation for future global development, we will evaluate safety, tolerability, pharmacokinetics, etc. in a Phase 1 study.
Clinical Trial Status
April 2026
The trial has been registered and made publicly available in the U.S. clinical trial database, ClinicalTrials.gov.
[Related News] [ClinicalTrials.gov Registration Information]
March 2026
The first patient has been dosed.